Coinspeaker Pfizer (PFE) Stock Down 7% after Setback with Breast Cancer TreatmentPfizer suffers a setback in trials targeted at getting Ibrance approved as an early-stage breast cancer therapy. As a result, PFE stock lost around 7% yesterday.Pfizer (PFE) Stock Down 7% after Setback with Breast Cancer Treatment